Drug recall
Apheresis Platelets, Platelet Additive Solution Added, Leukocytes Reduced
FDA recall event 87199 · Class II · American National Red Cross (The), Lewis and Clark Region
Key facts
| Event ID | 87199 |
|---|---|
| Recall numbers | B-0214-2021 |
| Recalling firm | American National Red Cross (The), Lewis and Clark Region |
| Product type | Biologics |
| Products | Apheresis Platelets, Platelet Additive Solution Added, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Plateletpheresis product, identified as unsuitable due to a collection deviation, was distributed. |
| Initiation date | Dec 18, 2020 |
| Report date | Feb 3, 2021 |
| Termination date | Jan 26, 2021 |
| City | Salt Lake City |
| State | UT |
| Country | United States |
| FEI number | 3001451955 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: